Statins reduce COVID-19 severity, likely by removing cholesterol that virus uses to infect — ScienceDaily
There are no Food and Drug Administration (FDA)-approved treatments for COVID-19, the pandemic infection caused by a novel coronavirus. While several therapies are being tested in clinical trials, current standard of care involves providing patients with fluids and fever-reducing medications. To speed the search for new COVID-19 therapies, researchers are testing repurposed drugs...
Prenatal Pot Use Impacts Kid’s Future Mental Health
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Sept. 23, 2020 (HealthDay News) -- Expectant mothers who smoke pot in pregnancy could increase their baby's risk for mental or emotional problems later in childhood, a new study finds.
...
Face-covering use up, more people are taking COVID-19 threats seriously, study finds — ScienceDaily
A new National Science Foundation-funded survey of six states has found that during the past two months, more people are wearing masks, vaccine uncertainty is on the rise, and many people are overestimating their risk of becoming seriously ill and dying from COVID-19.
The results are in a new report published this month by...
Colleges’ Opening Fueled 3,000 COVID Cases a Day, Researchers Say
Wednesday, September 23, 2020 (Kaiser News) -- Reopening colleges drove a coronavirus surge of about 3,000 new cases a day in the United States, according to a draft study released Tuesday.
The study, done jointly...
Glycans in the SARS-CoV-2 spike protein play active role in infection — ScienceDaily
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry. Now, researchers reporting in ACS Central Science...
Many Metrics to Measure COVID-19, Which Are Best?
Ali Mokdad, professor of health metrics sciences, Institute for Health Metrics and Evaluation; chief strategy officer for population health, University of Washington, Seattle.
Amesh Adalja, MD, senior scholar, Johns Hopkins...
Is rheumatoid arthritis two different diseases? — ScienceDaily
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues. The findings add to a growing body of evidence that...
COVID Hits Minorities Hardest in Nursing Homes, Too
TUESDAY, Sept. 22, 2020 (HealthDay News) -- Minority residents of U.S. nursing homes and assisted living communities have been especially hard hit in the coronavirus pandemic, two University of Rochester studies show.
The first found that nursing homes with higher percentages of racial and ethnic minority...
Cognitive problems stem from episodes of diabetic ketoacidosis — ScienceDaily
Diabetic ketoacidosis (DKA), a serious but common complication of type 1 diabetes, is linked to lower IQ scores and worse memory in children with type 1 diabetes, according to a study led by UC Davis Health researchers. The study published Sept. 22 in Diabetes Care is also the first large-scale work to differentiate...
Trial Holds Promise for Weekly Insulin for Type 2
By Serena Gordon HealthDay Reporter
TUESDAY, Sept. 22, 2020 (HealthDay News) -- Type 2 diabetes can be tough to control without medication. But for some people, the thought of daily shots makes them delay or avoid starting insulin therapy.
...
